(3)Commission Implementing Regulation (EU) 2022/159note approved the low-risk active substance Bacillus amyloliquefaciens strain IT-45. During the peer-review of the pesticide risk assessment of the active substance under Regulation (EC) No 1107/2009, the Authority concludednote, as regards the dietary risk assessment for consumers some information was not available and further consideration by risk managers was required. As set out in the review report for that substancenote, in the context of the risk assessment of the active substance under Regulation (EC) No 1107/2009Bacillus amyloliquefaciens strain IT-45 is not pathogenic to humans, is not expected to produce toxins that are relevant for human health and the risk to humans through metabolites is negligible. Taking into account the peer review of the pesticide risk assessment of the active substance Bacillus amyloliquefaciens strain IT-45, the review report and Article 5 and Article 14(2), point (a), (c) and (d), of Regulation (EC) No 396/2005, there is no need to establish MRLs for this substance and it is therefore appropriate to include Bacillus amyloliquefaciens strain IT-45 in Annex IV to Regulation (EC) No 396/2005.